 Patrick Carry
Concepts (429)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Scoliosis | 12 | 2024 | 216 | 3.400 |
Why?
| | DNA Methylation | 8 | 2025 | 644 | 2.240 |
Why?
| | Islets of Langerhans | 6 | 2025 | 803 | 1.940 |
Why?
| | Acetabulum | 17 | 2024 | 117 | 1.650 |
Why?
| | Autoimmunity | 8 | 2025 | 907 | 1.620 |
Why?
| | Hip Dislocation, Congenital | 11 | 2023 | 39 | 1.610 |
Why?
| | Diabetes Mellitus, Type 1 | 11 | 2025 | 3708 | 1.200 |
Why?
| | Hip Dislocation | 10 | 2025 | 55 | 1.160 |
Why?
| | Humeral Fractures | 8 | 2022 | 49 | 1.140 |
Why?
| | Spinal Fusion | 6 | 2022 | 251 | 1.100 |
Why?
| | Osteotomy | 12 | 2025 | 120 | 1.010 |
Why?
| | Fractures, Bone | 8 | 2023 | 419 | 1.010 |
Why?
| | Orthopedic Procedures | 10 | 2020 | 222 | 0.980 |
Why?
| | Adolescent | 65 | 2025 | 21555 | 0.940 |
Why?
| | Hip Joint | 11 | 2022 | 170 | 0.870 |
Why?
| | Child | 65 | 2025 | 22037 | 0.850 |
Why?
| | Genome-Wide Association Study | 4 | 2024 | 1436 | 0.800 |
Why?
| | Propensity Score | 3 | 2023 | 288 | 0.790 |
Why?
| | Orthopedics | 1 | 2025 | 151 | 0.790 |
Why?
| | Kyphosis | 1 | 2022 | 39 | 0.770 |
Why?
| | Disease Progression | 5 | 2024 | 2755 | 0.760 |
Why?
| | Blood Loss, Surgical | 3 | 2021 | 101 | 0.740 |
Why?
| | Patient Selection | 2 | 2025 | 691 | 0.730 |
Why?
| | Anterior Cruciate Ligament Reconstruction | 6 | 2019 | 143 | 0.730 |
Why?
| | Ultrasonic Therapy | 1 | 2021 | 15 | 0.720 |
Why?
| | Radiography | 21 | 2021 | 834 | 0.720 |
Why?
| | Brain Concussion | 6 | 2025 | 570 | 0.720 |
Why?
| | Seroconversion | 1 | 2021 | 46 | 0.700 |
Why?
| | Twins, Monozygotic | 1 | 2021 | 213 | 0.670 |
Why?
| | Diseases in Twins | 1 | 2021 | 175 | 0.670 |
Why?
| | Semicircular Canals | 1 | 2020 | 29 | 0.650 |
Why?
| | Femur Head | 4 | 2025 | 41 | 0.650 |
Why?
| | Autoantibodies | 3 | 2024 | 1501 | 0.650 |
Why?
| | Athletic Injuries | 7 | 2025 | 525 | 0.640 |
Why?
| | Femoracetabular Impingement | 5 | 2020 | 36 | 0.640 |
Why?
| | Humans | 111 | 2025 | 137514 | 0.630 |
Why?
| | Phospholipids | 1 | 2021 | 223 | 0.630 |
Why?
| | Retrospective Studies | 55 | 2025 | 15628 | 0.630 |
Why?
| | Return to Sport | 6 | 2025 | 96 | 0.630 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2025 | 1465 | 0.610 |
Why?
| | Postoperative Complications | 18 | 2020 | 2641 | 0.610 |
Why?
| | Biomedical Research | 1 | 2025 | 689 | 0.590 |
Why?
| | Ultrasonography | 6 | 2022 | 750 | 0.580 |
Why?
| | Surgeons | 1 | 2022 | 298 | 0.580 |
Why?
| | Upper Extremity | 2 | 2023 | 102 | 0.570 |
Why?
| | Joint Instability | 6 | 2022 | 170 | 0.570 |
Why?
| | Health Status | 1 | 2023 | 784 | 0.560 |
Why?
| | Female | 78 | 2025 | 73162 | 0.560 |
Why?
| | Male | 78 | 2025 | 67718 | 0.550 |
Why?
| | Child, Preschool | 22 | 2025 | 11097 | 0.550 |
Why?
| | Fracture Fixation | 3 | 2015 | 82 | 0.530 |
Why?
| | Algorithms | 2 | 2023 | 1702 | 0.520 |
Why?
| | Arteries | 1 | 2018 | 269 | 0.500 |
Why?
| | Fracture Fixation, Intramedullary | 4 | 2022 | 66 | 0.490 |
Why?
| | Femur | 5 | 2023 | 263 | 0.480 |
Why?
| | Clavicle | 3 | 2014 | 35 | 0.480 |
Why?
| | Tibial Fractures | 3 | 2023 | 75 | 0.470 |
Why?
| | Pain, Postoperative | 5 | 2018 | 272 | 0.430 |
Why?
| | Anterior Cruciate Ligament Injuries | 4 | 2019 | 159 | 0.430 |
Why?
| | Lower Extremity | 3 | 2023 | 427 | 0.420 |
Why?
| | Treatment Outcome | 31 | 2023 | 10821 | 0.390 |
Why?
| | Snow Sports | 1 | 2012 | 2 | 0.390 |
Why?
| | Reoperation | 7 | 2024 | 569 | 0.390 |
Why?
| | Oxylipins | 3 | 2023 | 40 | 0.390 |
Why?
| | Head Protective Devices | 1 | 2012 | 24 | 0.380 |
Why?
| | Femur Head Necrosis | 3 | 2016 | 9 | 0.380 |
Why?
| | Bias | 2 | 2025 | 221 | 0.380 |
Why?
| | Case-Control Studies | 9 | 2023 | 3546 | 0.370 |
Why?
| | Fracture Fixation, Internal | 7 | 2022 | 228 | 0.360 |
Why?
| | Epigenesis, Genetic | 4 | 2024 | 660 | 0.350 |
Why?
| | Patellofemoral Pain Syndrome | 1 | 2010 | 6 | 0.340 |
Why?
| | Pronation | 1 | 2010 | 10 | 0.340 |
Why?
| | Patellofemoral Joint | 1 | 2010 | 9 | 0.340 |
Why?
| | Epiphyses | 7 | 2021 | 26 | 0.340 |
Why?
| | Insulin | 2 | 2021 | 2398 | 0.330 |
Why?
| | Bone Nails | 4 | 2019 | 70 | 0.330 |
Why?
| | Osteogenesis Imperfecta | 2 | 2020 | 14 | 0.330 |
Why?
| | Tomography, X-Ray Computed | 4 | 2025 | 2681 | 0.310 |
Why?
| | Parent-Child Relations | 1 | 2012 | 272 | 0.310 |
Why?
| | Manipulation, Orthopedic | 3 | 2019 | 7 | 0.310 |
Why?
| | Imaging, Three-Dimensional | 2 | 2025 | 581 | 0.300 |
Why?
| | Magnetic Resonance Imaging | 6 | 2022 | 3722 | 0.300 |
Why?
| | Severity of Illness Index | 7 | 2021 | 2838 | 0.300 |
Why?
| | Radiation Dosage | 3 | 2025 | 174 | 0.290 |
Why?
| | Clubfoot | 2 | 2019 | 6 | 0.280 |
Why?
| | Casts, Surgical | 2 | 2019 | 26 | 0.280 |
Why?
| | Range of Motion, Articular | 8 | 2025 | 392 | 0.270 |
Why?
| | Knee Joint | 4 | 2025 | 405 | 0.270 |
Why?
| | Young Adult | 18 | 2025 | 13243 | 0.270 |
Why?
| | Biomechanical Phenomena | 7 | 2025 | 768 | 0.270 |
Why?
| | Slipped Capital Femoral Epiphyses | 2 | 2018 | 7 | 0.260 |
Why?
| | Spine | 2 | 2018 | 174 | 0.250 |
Why?
| | Risk Factors | 16 | 2023 | 10356 | 0.250 |
Why?
| | Cadaver | 3 | 2022 | 319 | 0.250 |
Why?
| | Sports | 2 | 2022 | 229 | 0.250 |
Why?
| | Prevalence | 4 | 2022 | 2719 | 0.250 |
Why?
| | Cohort Studies | 8 | 2021 | 5730 | 0.250 |
Why?
| | Clinical Protocols | 2 | 2018 | 268 | 0.250 |
Why?
| | Surgical Wound Infection | 3 | 2018 | 306 | 0.250 |
Why?
| | Charcot-Marie-Tooth Disease | 2 | 2016 | 23 | 0.240 |
Why?
| | Athletes | 5 | 2022 | 406 | 0.230 |
Why?
| | Knee | 1 | 2025 | 67 | 0.230 |
Why?
| | Infant | 13 | 2023 | 9467 | 0.230 |
Why?
| | Genetic Predisposition to Disease | 3 | 2023 | 2420 | 0.230 |
Why?
| | Tibia | 2 | 2023 | 177 | 0.230 |
Why?
| | Tibial Meniscus Injuries | 2 | 2015 | 48 | 0.220 |
Why?
| | Proprioception | 1 | 2024 | 26 | 0.220 |
Why?
| | Cartilage, Articular | 2 | 2020 | 309 | 0.220 |
Why?
| | Elbow Joint | 3 | 2019 | 71 | 0.220 |
Why?
| | Sternoclavicular Joint | 2 | 2014 | 11 | 0.220 |
Why?
| | Walking | 2 | 2025 | 516 | 0.210 |
Why?
| | Dizziness | 1 | 2024 | 83 | 0.210 |
Why?
| | Radiation Exposure | 1 | 2024 | 49 | 0.210 |
Why?
| | Orthotic Devices | 3 | 2022 | 22 | 0.210 |
Why?
| | Odds Ratio | 8 | 2019 | 1063 | 0.210 |
Why?
| | Adult | 21 | 2025 | 37821 | 0.210 |
Why?
| | HLA-DR4 Antigen | 2 | 2021 | 78 | 0.210 |
Why?
| | Time Factors | 13 | 2021 | 6817 | 0.210 |
Why?
| | HLA-DR3 Antigen | 2 | 2021 | 80 | 0.210 |
Why?
| | Cervical Vertebrae | 1 | 2024 | 135 | 0.200 |
Why?
| | Humerus | 2 | 2022 | 41 | 0.200 |
Why?
| | Growth Plate | 2 | 2023 | 36 | 0.200 |
Why?
| | Longitudinal Studies | 3 | 2025 | 2857 | 0.200 |
Why?
| | Follow-Up Studies | 11 | 2024 | 5139 | 0.200 |
Why?
| | Meniere Disease | 1 | 2023 | 32 | 0.200 |
Why?
| | Ligaments, Articular | 1 | 2022 | 52 | 0.190 |
Why?
| | Gait Disorders, Neurologic | 1 | 2022 | 45 | 0.190 |
Why?
| | Wrist Joint | 1 | 2022 | 65 | 0.190 |
Why?
| | Spinal Fractures | 1 | 2023 | 84 | 0.190 |
Why?
| | Hip Fractures | 1 | 2023 | 95 | 0.190 |
Why?
| | Radius Fractures | 1 | 2022 | 60 | 0.190 |
Why?
| | Orthopedic Surgeons | 1 | 2022 | 27 | 0.190 |
Why?
| | Ankle Fractures | 1 | 2022 | 23 | 0.180 |
Why?
| | Legg-Calve-Perthes Disease | 1 | 2021 | 4 | 0.180 |
Why?
| | Deafness | 1 | 2023 | 80 | 0.180 |
Why?
| | Migraine Disorders | 1 | 2023 | 104 | 0.180 |
Why?
| | Carnitine O-Palmitoyltransferase | 1 | 2021 | 46 | 0.180 |
Why?
| | Quadriceps Muscle | 3 | 2022 | 131 | 0.180 |
Why?
| | Selection Bias | 1 | 2021 | 37 | 0.180 |
Why?
| | Bone Plates | 2 | 2022 | 85 | 0.180 |
Why?
| | Orthognathic Surgical Procedures | 1 | 2001 | 5 | 0.180 |
Why?
| | Age Factors | 7 | 2021 | 3301 | 0.180 |
Why?
| | Neck Muscles | 1 | 2021 | 18 | 0.180 |
Why?
| | Prosthesis Fitting | 1 | 2020 | 17 | 0.170 |
Why?
| | Incidence | 8 | 2023 | 2792 | 0.170 |
Why?
| | Cerebral Palsy | 1 | 2022 | 112 | 0.170 |
Why?
| | Suture Techniques | 2 | 2019 | 122 | 0.170 |
Why?
| | Lumbar Vertebrae | 1 | 2022 | 245 | 0.170 |
Why?
| | Probability | 1 | 2021 | 311 | 0.170 |
Why?
| | Arthralgia | 2 | 2020 | 55 | 0.170 |
Why?
| | Monitoring, Intraoperative | 2 | 2016 | 56 | 0.170 |
Why?
| | Pelvic Bones | 1 | 2023 | 162 | 0.170 |
Why?
| | Proportional Hazards Models | 2 | 2021 | 1263 | 0.160 |
Why?
| | Muscle Strength | 2 | 2021 | 315 | 0.160 |
Why?
| | Infant Nutritional Physiological Phenomena | 1 | 2021 | 144 | 0.160 |
Why?
| | Patella | 1 | 2019 | 24 | 0.160 |
Why?
| | Recreation | 1 | 2019 | 23 | 0.160 |
Why?
| | Play and Playthings | 1 | 2019 | 34 | 0.160 |
Why?
| | Intraoperative Complications | 1 | 2001 | 140 | 0.160 |
Why?
| | Histology | 1 | 2019 | 4 | 0.160 |
Why?
| | Bone-Patellar Tendon-Bone Grafting | 1 | 2019 | 11 | 0.150 |
Why?
| | Education, Professional | 1 | 2019 | 18 | 0.150 |
Why?
| | Equipment Failure | 1 | 2019 | 108 | 0.150 |
Why?
| | Health Occupations | 1 | 2019 | 33 | 0.150 |
Why?
| | Gene Frequency | 1 | 2020 | 521 | 0.150 |
Why?
| | Research Design | 1 | 2025 | 1116 | 0.150 |
Why?
| | Tendons | 1 | 2019 | 111 | 0.150 |
Why?
| | Computer-Assisted Instruction | 1 | 2019 | 65 | 0.150 |
Why?
| | Logistic Models | 5 | 2017 | 2064 | 0.150 |
Why?
| | Interleukins | 1 | 2020 | 251 | 0.140 |
Why?
| | Pattern Recognition, Visual | 1 | 2019 | 103 | 0.140 |
Why?
| | Prader-Willi Syndrome | 1 | 2018 | 27 | 0.140 |
Why?
| | Prospective Studies | 8 | 2025 | 7598 | 0.140 |
Why?
| | Anesthesia, Local | 1 | 2018 | 19 | 0.140 |
Why?
| | Analgesia, Patient-Controlled | 1 | 2018 | 13 | 0.140 |
Why?
| | Genetic Association Studies | 1 | 2020 | 377 | 0.140 |
Why?
| | Femoral Nerve | 1 | 2018 | 19 | 0.140 |
Why?
| | Bone Malalignment | 1 | 2017 | 13 | 0.140 |
Why?
| | Meningomyelocele | 1 | 2018 | 59 | 0.140 |
Why?
| | CpG Islands | 3 | 2023 | 160 | 0.140 |
Why?
| | Quantitative Trait Loci | 1 | 2020 | 381 | 0.140 |
Why?
| | Sciatic Nerve | 1 | 2018 | 58 | 0.140 |
Why?
| | Smoking | 1 | 2025 | 1639 | 0.140 |
Why?
| | Arthroscopy | 2 | 2020 | 219 | 0.140 |
Why?
| | Analgesia, Epidural | 1 | 2018 | 33 | 0.140 |
Why?
| | Collagen | 1 | 2020 | 447 | 0.140 |
Why?
| | Femoral Fractures | 1 | 2018 | 78 | 0.140 |
Why?
| | Antibiotic Prophylaxis | 1 | 2018 | 117 | 0.130 |
Why?
| | Nerve Block | 1 | 2018 | 76 | 0.130 |
Why?
| | Neoplasm Proteins | 1 | 2020 | 433 | 0.130 |
Why?
| | Learning Curve | 1 | 2017 | 72 | 0.130 |
Why?
| | Epiphyses, Slipped | 1 | 2016 | 4 | 0.130 |
Why?
| | Immunity, Innate | 1 | 2022 | 832 | 0.130 |
Why?
| | Cumulative Trauma Disorders | 1 | 2016 | 42 | 0.130 |
Why?
| | Open Fracture Reduction | 1 | 2016 | 35 | 0.130 |
Why?
| | ST Elevation Myocardial Infarction | 1 | 2016 | 54 | 0.120 |
Why?
| | Substance-Related Disorders | 1 | 2025 | 1079 | 0.120 |
Why?
| | Postoperative Hemorrhage | 1 | 2016 | 88 | 0.120 |
Why?
| | Metabolomics | 1 | 2021 | 679 | 0.120 |
Why?
| | Depression | 1 | 2025 | 1408 | 0.120 |
Why?
| | Electrocardiography | 2 | 2016 | 632 | 0.120 |
Why?
| | Pain | 1 | 2022 | 836 | 0.120 |
Why?
| | Radius | 1 | 2015 | 38 | 0.120 |
Why?
| | Cross-Sectional Studies | 3 | 2018 | 5427 | 0.120 |
Why?
| | Muscle, Skeletal | 1 | 2025 | 1701 | 0.120 |
Why?
| | Shoulder Fractures | 1 | 2015 | 13 | 0.120 |
Why?
| | Predictive Value of Tests | 5 | 2020 | 2039 | 0.120 |
Why?
| | Nonprescription Drugs | 1 | 2015 | 66 | 0.110 |
Why?
| | Forecasting | 1 | 2016 | 386 | 0.110 |
Why?
| | Soft Tissue Injuries | 1 | 2015 | 40 | 0.110 |
Why?
| | Histiocytosis, Langerhans-Cell | 1 | 2014 | 38 | 0.110 |
Why?
| | Unnecessary Procedures | 1 | 2015 | 49 | 0.110 |
Why?
| | Practice Patterns, Physicians' | 2 | 2015 | 1312 | 0.110 |
Why?
| | Menisci, Tibial | 1 | 2014 | 61 | 0.110 |
Why?
| | Autografts | 1 | 2014 | 45 | 0.110 |
Why?
| | Elective Surgical Procedures | 1 | 2016 | 182 | 0.110 |
Why?
| | Bone Marrow Transplantation | 1 | 2015 | 286 | 0.110 |
Why?
| | United States | 10 | 2025 | 14696 | 0.110 |
Why?
| | Long QT Syndrome | 1 | 2015 | 70 | 0.110 |
Why?
| | Bone Diseases | 1 | 2014 | 63 | 0.110 |
Why?
| | Caregivers | 1 | 2022 | 872 | 0.110 |
Why?
| | Prescription Drugs | 1 | 2015 | 110 | 0.110 |
Why?
| | Patient Compliance | 1 | 2018 | 586 | 0.110 |
Why?
| | Allografts | 1 | 2014 | 148 | 0.110 |
Why?
| | Venous Thrombosis | 1 | 2016 | 187 | 0.110 |
Why?
| | Diet | 1 | 2021 | 1273 | 0.110 |
Why?
| | Joint Dislocations | 1 | 2014 | 52 | 0.100 |
Why?
| | Cartilage | 1 | 2015 | 188 | 0.100 |
Why?
| | Obesity | 3 | 2015 | 2974 | 0.100 |
Why?
| | Pulmonary Embolism | 1 | 2016 | 222 | 0.100 |
Why?
| | Risk Assessment | 7 | 2017 | 3439 | 0.100 |
Why?
| | Shoulder Dislocation | 1 | 2014 | 50 | 0.100 |
Why?
| | Exercise | 1 | 2025 | 2024 | 0.100 |
Why?
| | Injury Severity Score | 3 | 2023 | 525 | 0.100 |
Why?
| | Chi-Square Distribution | 4 | 2015 | 533 | 0.100 |
Why?
| | Intra-Articular Fractures | 1 | 2012 | 19 | 0.100 |
Why?
| | Clinical Competence | 2 | 2017 | 1093 | 0.100 |
Why?
| | Bupivacaine | 1 | 2012 | 32 | 0.100 |
Why?
| | Kaplan-Meier Estimate | 4 | 2016 | 892 | 0.100 |
Why?
| | Body Mass Index | 3 | 2016 | 2369 | 0.100 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2020 | 2193 | 0.090 |
Why?
| | Amides | 1 | 2012 | 93 | 0.090 |
Why?
| | Pediatrics | 1 | 2020 | 1123 | 0.090 |
Why?
| | Anemia, Sickle Cell | 1 | 2015 | 266 | 0.090 |
Why?
| | Multivariate Analysis | 4 | 2017 | 1524 | 0.090 |
Why?
| | Bone and Bones | 1 | 2014 | 317 | 0.090 |
Why?
| | Treatment Failure | 3 | 2019 | 353 | 0.090 |
Why?
| | Graft Survival | 1 | 2014 | 540 | 0.090 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2023 | 2521 | 0.090 |
Why?
| | Guideline Adherence | 1 | 2015 | 549 | 0.090 |
Why?
| | Operative Time | 3 | 2017 | 147 | 0.090 |
Why?
| | Gait | 2 | 2025 | 280 | 0.090 |
Why?
| | Linear Models | 3 | 2021 | 851 | 0.090 |
Why?
| | Recovery of Function | 4 | 2016 | 662 | 0.090 |
Why?
| | Reproducibility of Results | 4 | 2020 | 3292 | 0.080 |
Why?
| | Emergency Medical Services | 1 | 2016 | 548 | 0.080 |
Why?
| | Craniocerebral Trauma | 1 | 2012 | 168 | 0.080 |
Why?
| | North America | 1 | 2011 | 313 | 0.080 |
Why?
| | Aged, 80 and over | 2 | 2021 | 7593 | 0.080 |
Why?
| | Analgesics, Opioid | 1 | 2018 | 1002 | 0.080 |
Why?
| | Torque | 2 | 2021 | 82 | 0.080 |
Why?
| | Trauma Centers | 2 | 2022 | 422 | 0.080 |
Why?
| | Data Collection | 1 | 2012 | 674 | 0.080 |
Why?
| | Sex Factors | 3 | 2021 | 2074 | 0.080 |
Why?
| | Health Care Surveys | 1 | 2011 | 567 | 0.080 |
Why?
| | Facial Bones | 2 | 2001 | 30 | 0.070 |
Why?
| | Neuromuscular Diseases | 1 | 2010 | 124 | 0.070 |
Why?
| | Mice | 2 | 2023 | 17843 | 0.070 |
Why?
| | Postoperative Care | 3 | 2015 | 258 | 0.070 |
Why?
| | Anti-Bacterial Agents | 1 | 2018 | 1800 | 0.070 |
Why?
| | Equipment Failure Analysis | 2 | 2020 | 132 | 0.070 |
Why?
| | Observer Variation | 2 | 2018 | 347 | 0.070 |
Why?
| | Regression Analysis | 2 | 2019 | 1029 | 0.070 |
Why?
| | Self Report | 2 | 2025 | 831 | 0.070 |
Why?
| | Bone Transplantation | 2 | 2019 | 95 | 0.060 |
Why?
| | Middle Aged | 8 | 2025 | 33355 | 0.060 |
Why?
| | Equipment Design | 2 | 2019 | 526 | 0.060 |
Why?
| | Hemodilution | 2 | 1996 | 10 | 0.060 |
Why?
| | Patient Care Team | 1 | 2010 | 629 | 0.060 |
Why?
| | Prognosis | 3 | 2020 | 4031 | 0.060 |
Why?
| | Infant, Newborn | 4 | 2019 | 6059 | 0.060 |
Why?
| | Knee Injuries | 2 | 2015 | 100 | 0.050 |
Why?
| | Vestibule, Labyrinth | 1 | 2024 | 67 | 0.050 |
Why?
| | Fluoroscopy | 1 | 2024 | 162 | 0.050 |
Why?
| | Animals | 2 | 2023 | 37011 | 0.050 |
Why?
| | GTPase-Activating Proteins | 1 | 2023 | 82 | 0.050 |
Why?
| | Reaction Time | 1 | 2025 | 432 | 0.050 |
Why?
| | X-Rays | 1 | 2022 | 29 | 0.050 |
Why?
| | Electromyography | 1 | 2025 | 400 | 0.050 |
Why?
| | Operating Rooms | 1 | 2024 | 122 | 0.050 |
Why?
| | Vertigo | 1 | 2023 | 39 | 0.050 |
Why?
| | Pain Measurement | 2 | 2018 | 552 | 0.050 |
Why?
| | Colorado | 3 | 2018 | 4521 | 0.050 |
Why?
| | Ascorbic Acid | 1 | 2023 | 123 | 0.050 |
Why?
| | Patient Satisfaction | 2 | 2018 | 657 | 0.050 |
Why?
| | Pelvis | 1 | 2023 | 112 | 0.050 |
Why?
| | Physical Therapy Modalities | 2 | 2015 | 309 | 0.050 |
Why?
| | Extracellular Matrix Proteins | 1 | 2023 | 153 | 0.050 |
Why?
| | Anatomic Variation | 1 | 2021 | 3 | 0.050 |
Why?
| | Fracture Healing | 1 | 2022 | 82 | 0.050 |
Why?
| | Catheters | 1 | 2022 | 72 | 0.050 |
Why?
| | Peripheral Nerves | 1 | 2022 | 70 | 0.050 |
Why?
| | Epidemiologic Studies | 1 | 2021 | 73 | 0.050 |
Why?
| | Standard of Care | 1 | 2022 | 74 | 0.050 |
Why?
| | Preanesthetic Medication | 1 | 2001 | 3 | 0.040 |
Why?
| | Chin | 1 | 2001 | 5 | 0.040 |
Why?
| | Osteotomy, Le Fort | 1 | 2001 | 3 | 0.040 |
Why?
| | Pulmonary Atelectasis | 1 | 2001 | 15 | 0.040 |
Why?
| | Linoleic Acid | 1 | 2021 | 44 | 0.040 |
Why?
| | Postoperative Nausea and Vomiting | 1 | 2001 | 15 | 0.040 |
Why?
| | Malocclusion | 1 | 2001 | 25 | 0.040 |
Why?
| | Receptor-Like Protein Tyrosine Phosphatases, Class 8 | 1 | 2021 | 63 | 0.040 |
Why?
| | Muscle Strength Dynamometer | 1 | 2021 | 23 | 0.040 |
Why?
| | Arachidonic Acid | 1 | 2021 | 120 | 0.040 |
Why?
| | Work | 1 | 2020 | 18 | 0.040 |
Why?
| | Osteogenesis, Distraction | 1 | 2001 | 16 | 0.040 |
Why?
| | Musculoskeletal System | 1 | 2021 | 48 | 0.040 |
Why?
| | Glutamate Decarboxylase | 1 | 2021 | 170 | 0.040 |
Why?
| | Docosahexaenoic Acids | 1 | 2021 | 84 | 0.040 |
Why?
| | Blood | 1 | 2001 | 106 | 0.040 |
Why?
| | Anesthesia, General | 1 | 2001 | 73 | 0.040 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2020 | 47 | 0.040 |
Why?
| | Emergency Service, Hospital | 2 | 2023 | 2054 | 0.040 |
Why?
| | Patellar Ligament | 1 | 2019 | 25 | 0.040 |
Why?
| | Functional Laterality | 1 | 2020 | 229 | 0.040 |
Why?
| | Foreign Bodies | 1 | 2001 | 104 | 0.040 |
Why?
| | Nerve Tissue Proteins | 1 | 2023 | 599 | 0.040 |
Why?
| | Athletic Performance | 1 | 2020 | 76 | 0.040 |
Why?
| | Epidemiological Monitoring | 1 | 2019 | 60 | 0.040 |
Why?
| | Fetal Blood | 1 | 2021 | 327 | 0.040 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2021 | 765 | 0.040 |
Why?
| | Educational Status | 1 | 2022 | 483 | 0.040 |
Why?
| | Students | 1 | 2025 | 625 | 0.040 |
Why?
| | Sutures | 1 | 2019 | 59 | 0.040 |
Why?
| | Ligaments | 1 | 2019 | 60 | 0.040 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2020 | 139 | 0.040 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2021 | 595 | 0.040 |
Why?
| | Isometric Contraction | 1 | 2021 | 188 | 0.040 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2025 | 608 | 0.040 |
Why?
| | Students, Health Occupations | 1 | 2019 | 34 | 0.040 |
Why?
| | Eye Movements | 1 | 2019 | 67 | 0.040 |
Why?
| | Anterior Cruciate Ligament | 1 | 2019 | 81 | 0.040 |
Why?
| | Professional Competence | 1 | 2019 | 100 | 0.040 |
Why?
| | Comorbidity | 2 | 2015 | 1618 | 0.040 |
Why?
| | Hospitals | 1 | 2023 | 678 | 0.040 |
Why?
| | Random Allocation | 1 | 2019 | 357 | 0.040 |
Why?
| | Video Recording | 1 | 2019 | 184 | 0.040 |
Why?
| | Tandem Mass Spectrometry | 1 | 2021 | 533 | 0.040 |
Why?
| | Breast Feeding | 1 | 2021 | 439 | 0.040 |
Why?
| | Thoracic Vertebrae | 1 | 2018 | 78 | 0.030 |
Why?
| | Risk Management | 1 | 2018 | 91 | 0.030 |
Why?
| | Organ Size | 1 | 2018 | 479 | 0.030 |
Why?
| | Device Removal | 1 | 2018 | 138 | 0.030 |
Why?
| | Early Diagnosis | 1 | 2018 | 244 | 0.030 |
Why?
| | Calcium | 1 | 2023 | 1233 | 0.030 |
Why?
| | Age of Onset | 1 | 2018 | 522 | 0.030 |
Why?
| | Ileostomy | 1 | 1996 | 20 | 0.030 |
Why?
| | Intracranial Pressure | 1 | 2016 | 47 | 0.030 |
Why?
| | Intestinal Fistula | 1 | 1996 | 17 | 0.030 |
Why?
| | Ribs | 1 | 2015 | 35 | 0.030 |
Why?
| | Inservice Training | 1 | 2016 | 113 | 0.030 |
Why?
| | Missouri | 1 | 2015 | 63 | 0.030 |
Why?
| | Patient Outcome Assessment | 1 | 2016 | 132 | 0.030 |
Why?
| | Methylprednisolone | 1 | 1996 | 85 | 0.030 |
Why?
| | Databases, Factual | 1 | 2021 | 1351 | 0.030 |
Why?
| | Intestinal Obstruction | 1 | 1996 | 50 | 0.030 |
Why?
| | Area Under Curve | 1 | 2016 | 316 | 0.030 |
Why?
| | Postoperative Period | 1 | 2016 | 344 | 0.030 |
Why?
| | Matched-Pair Analysis | 1 | 2015 | 40 | 0.030 |
Why?
| | Radiologic Health | 1 | 2015 | 4 | 0.030 |
Why?
| | Titanium | 1 | 2015 | 82 | 0.030 |
Why?
| | Rotation | 1 | 2015 | 116 | 0.030 |
Why?
| | Curettage | 1 | 2014 | 8 | 0.030 |
Why?
| | Practice Guidelines as Topic | 2 | 2015 | 1580 | 0.030 |
Why?
| | Esthetics | 1 | 2015 | 52 | 0.030 |
Why?
| | Medical Records | 1 | 2015 | 173 | 0.030 |
Why?
| | Transplantation, Autologous | 1 | 2015 | 238 | 0.030 |
Why?
| | Trauma Severity Indices | 1 | 2015 | 106 | 0.030 |
Why?
| | Lysholm Knee Score | 1 | 2014 | 8 | 0.030 |
Why?
| | Skull | 1 | 1996 | 139 | 0.030 |
Why?
| | Cost Savings | 1 | 2015 | 83 | 0.030 |
Why?
| | Coxa Valga | 1 | 2014 | 1 | 0.030 |
Why?
| | ROC Curve | 1 | 2016 | 547 | 0.030 |
Why?
| | Edema | 1 | 1995 | 129 | 0.030 |
Why?
| | Pain Management | 1 | 2018 | 363 | 0.030 |
Why?
| | Regional Blood Flow | 1 | 2016 | 474 | 0.030 |
Why?
| | Immobilization | 1 | 2014 | 44 | 0.030 |
Why?
| | Physical Examination | 1 | 2015 | 241 | 0.030 |
Why?
| | Age Distribution | 1 | 2015 | 391 | 0.030 |
Why?
| | Finite Element Analysis | 1 | 2014 | 75 | 0.030 |
Why?
| | Sex Distribution | 1 | 2015 | 378 | 0.030 |
Why?
| | Occupational Therapy | 1 | 2015 | 99 | 0.030 |
Why?
| | Face | 1 | 1995 | 175 | 0.030 |
Why?
| | Osteoarthritis, Hip | 1 | 2014 | 45 | 0.030 |
Why?
| | Hospitalization | 1 | 2023 | 2197 | 0.030 |
Why?
| | Preoperative Care | 1 | 2015 | 356 | 0.030 |
Why?
| | Injections, Intra-Articular | 1 | 2012 | 47 | 0.020 |
Why?
| | Pregnancy | 1 | 2025 | 6745 | 0.020 |
Why?
| | Anesthetics, Local | 1 | 2012 | 80 | 0.020 |
Why?
| | Anti-Inflammatory Agents | 1 | 1996 | 498 | 0.020 |
Why?
| | Single-Blind Method | 1 | 2012 | 288 | 0.020 |
Why?
| | Disease Management | 1 | 2015 | 625 | 0.020 |
Why?
| | Quality of Life | 1 | 2023 | 2870 | 0.020 |
Why?
| | Biopsy | 1 | 2014 | 1132 | 0.020 |
Why?
| | Communication | 1 | 2016 | 874 | 0.020 |
Why?
| | Drug Administration Schedule | 1 | 2012 | 784 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2012 | 1324 | 0.020 |
Why?
| | Quality Improvement | 1 | 2018 | 1161 | 0.020 |
Why?
| | Hospitals, Pediatric | 1 | 2012 | 533 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2012 | 2066 | 0.020 |
Why?
| | Lung | 1 | 2001 | 4066 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2019 | 5772 | 0.020 |
Why?
| | Acute-Phase Proteins | 2 | 1996 | 67 | 0.020 |
Why?
| | Critical Care | 1 | 2010 | 584 | 0.010 |
Why?
| | Aged | 2 | 2022 | 23798 | 0.010 |
Why?
| | Inflammation | 1 | 1996 | 2837 | 0.010 |
Why?
| | Length of Stay | 1 | 2010 | 1210 | 0.010 |
Why?
| | Orosomucoid | 1 | 1995 | 8 | 0.010 |
Why?
| | Telemetry | 1 | 1995 | 40 | 0.010 |
Why?
| | Blood Volume | 1 | 1995 | 61 | 0.010 |
Why?
| | Hematocrit | 1 | 1995 | 95 | 0.010 |
Why?
| | Haptoglobins | 1 | 1995 | 53 | 0.010 |
Why?
| | Morbidity | 1 | 1996 | 322 | 0.010 |
Why?
| | Mandible | 1 | 1995 | 79 | 0.010 |
Why?
| | Rectal Neoplasms | 1 | 1996 | 149 | 0.010 |
Why?
| | Colitis, Ulcerative | 1 | 1996 | 135 | 0.010 |
Why?
| | Fibrinogen | 1 | 1995 | 170 | 0.010 |
Why?
| | C-Reactive Protein | 1 | 1995 | 411 | 0.010 |
Why?
| | Crohn Disease | 1 | 1996 | 242 | 0.010 |
Why?
|
|
Carry's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|